Biocryst Pharmaceuticals Inc
BCRX
Revenue
3.89M
▼-4.87M▼-55.59%
3 Months ChangeAssets
472.42M
▲4.53M▲0.9675%
3 Months ChangeLiabilities
948.03M
▲3.97M▲0.4201%
3 Months ChangeFree Cash Flow
-53.92M
▼-6.25M▼-13.10%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-02
Form 8-K
ID: 0001171843-24-005439
2024-09-30
Form 8-K
ID: 0001171843-24-005393
2024-08-06
Form 10-Q
ID: 0001628280-24-035170
2024-08-05
Form 8-K
ID: 0001171843-24-004422
2024-06-13
Form 8-K
ID: 0001171843-24-003430
2024-05-07
Form 10-Q
ID: 0001628280-24-021069
2024-05-06
Form 8-K
ID: 0001171843-24-002550
2024-02-26
Form 8-K
ID: 0001171843-24-000967
2024-01-18
Form 8-K
ID: 0001171843-24-000297
2024-01-08
Form 8-K
ID: 0001171843-24-000112